Biggest News Aggregation in the World

📰 Duration Psychedelics Development News

Duration Psychedelics Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Duration Psychedelics Development. Real-time updates on events, politics, business and more.

First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression

April 26, 2024

Beckley Psytech Rob Conley Beckley Psytech Ltd Duration Psychedelics Development Atai Invests Beckley Psytech For Short Duration Psychedelics

Source: benzinga.com

Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

January 7, 2024

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

United States Enveric Biosciences Russell Coleman Beckley Psytech Nolan Williams Bryan Hubbard

Source: benzinga.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science